ContentsSynopsisCodesLook ForDiagnostic PearlsDifferential Diagnosis & PitfallsBest TestsManagement PearlsTherapyDrug Reaction DataReferencesView all Images (23)
Exogenous ochronosis
Other Resources UpToDate PubMed

Exogenous ochronosis

Contributors: Edward Li PhD, Chris G. Adigun MD, Belinda Tan MD, PhD, Susan Burgin MD
Other Resources UpToDate PubMed

Synopsis

Exogenous ochronosis is the brown-black skin discoloration that occurs as a result of dermal accumulation of homogentisic acid. The most common cause of exogenous ochronosis is application of topical hydroquinone as part of the formulation in a variety of skin bleaching creams. It has also been reported to occur secondary to systemic antimalarials (ie, quinine, hydroxychloroquine) and the topical application of phenol derivatives, resorcinol, picric acid, and mercury. Resorcinol and mercury were historically added to hydroquinone-containing bleaching creams in unregulated preparations in some countries.

The pigmentation usually presents as dark brown, black, or blue-black macules, particularly over the zygoma and orbital ridges, but any other facial surface or skin coming into chronic contact with causative agents may be affected. It may be preceded by erythema, and, in advanced cases, papules and nodules may ensue.

Exogenous ochronosis from topical hydroquinone occurs most frequently in individuals with skin phototypes IV-VI, but individuals with lighter skin phototypes may be affected as well. Onset has been reported as soon as 6 months of use. While the condition is usually associated with the prolonged use of skin lightening creams containing higher concentrations of hydroquinone, it has also been reported with the use of lower concentrations for shorter periods. The high incidence in South Africa has been postulated to occur secondary to the use of unregulated products with higher hydroquinone concentrations and resorcinol and mercury additives.

The pathogenic mechanism is unclear, but the leading hypothesis suggests that hydroquinone and other known causative agents cause local inhibition of homogentisic acid (HGA) oxidase, an enzyme in the tyrosine metabolic pathway required to break down HGA, thereby leading to an accumulation of HGA in the skin. HGA then polymerizes and forms ochronotic pigments in the dermis.

Related topic: Alkaptonuria

Codes

ICD10CM:
L81.9 – Disorder of pigmentation, unspecified

SNOMEDCT:
410041002 – Exogenous ochronosis

Look For

Subscription Required

Diagnostic Pearls

Subscription Required

Differential Diagnosis & Pitfalls

Best Tests

Subscription Required

Management Pearls

Subscription Required

Therapy

Subscription Required

Drug Reaction Data

Below is a list of drugs with literature evidence indicating an adverse association with this diagnosis. The list is continually updated through ongoing research and new medication approvals. Click on Citations to sort by number of citations or click on Medication to sort the medications alphabetically.

Subscription Required

References

Subscription Required

Last Reviewed:11/03/2019
Last Updated:02/12/2020
Copyright © 2021 VisualDx®. All rights reserved.